North Point Portfolio Managers’s AbbVie ABBV Stock Holding History

North Point Portfolio Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585K	Sell	2,323 -150	-6%	-$32.3K	0.1%	51
2026 Q1	$538K	Hold	2,473	–	–	0.1%	50
2025 Q4	$565K	Hold	2,473	–	–	0.1%	49
2025 Q3	$573K	Hold	2,473	–	–	0.09%	49
2025 Q2	$459K	Hold	2,473	–	–	0.08%	50
2025 Q1	$518K	Buy	+2,473	New	+$481K	0.09%	51
2024 Q4	–	Sell	-3,929	Closed	-$776K	–	70
2024 Q3	$776K	Buy	+3,929	New	+$733K	0.12%	54
2015 Q1	–	Sell	-131,142	Closed	-$8.58M	–	84
2014 Q4	$8.58M	Buy	131,142 +801	+0.6%	+$50.5K	1.64%	35
2014 Q3	$7.53M	Sell	130,341 -2,265	-2%	-$126K	1.51%	39
2014 Q2	$7.48M	Buy	132,606 +687	+0.5%	+$36K	1.51%	39
2014 Q1	$6.78M	Buy	131,919 +2,082	+2%	+$105K	1.44%	39
2013 Q4	$6.86M	Buy	129,837 +612	+0.5%	+$30.1K	1.46%	39
2013 Q3	$5.78M	Sell	129,225 -1,097	-0.8%	-$48.6K	1.36%	38
2013 Q2	$5.39M	Buy	+130,322	New	+$5.7M	1.35%	38

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

North Point Portfolio Managers's ABBV Position: Q2 2026 in Review

North Point Portfolio Managers reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $32.3K and leaving 2,323 shares worth $585K. The position accounts for 0.1% of the portfolio, ranked #51.

North Point Portfolio Managers first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $8.58M in Q4 2014. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

North Point Portfolio Managers held 2,323 shares of AbbVie worth $585K as of Q2 2026.
North Point Portfolio Managers sold 150 AbbVie shares in Q2 2026, an estimated $32.3K.
AbbVie made up 0.1% of North Point Portfolio Managers's portfolio in Q2 2026, its #51 holding.
North Point Portfolio Managers first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
North Point Portfolio Managers's AbbVie position peaked at $8.58M in Q4 2014.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on North Point Portfolio Managers's 13F filing for Q2 2026, filed 31 Jul 2026.